|
|
Volumn 19, Issue 5-6, 2005, Pages 285-288
|
|
Rare diseases and essential medicines: Global perspective
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
ORPHAN DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT RESPIRATORY DISTRESS SYNDROME;
AFRICAN TRYPANOSOMIASIS;
BURULI ULCER;
CHAGAS DISEASE;
COST EFFECTIVENESS ANALYSIS;
CYSTIC FIBROSIS;
DEVELOPED COUNTRY;
DEVELOPING COUNTRY;
DRUG CONTROL;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG USE;
DRUG UTILIZATION;
GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY;
HEALTH CARE;
HEALTH CARE ACCESS;
HEALTH CARE PLANNING;
HEALTH PROGRAM;
HEMOPHILIA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INDUSTRIAL AREA;
LEISHMANIASIS;
LOWEST INCOME GROUP;
MALARIA;
MARKET;
ORGANIZATION AND MANAGEMENT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RARE DISEASE;
REIMBURSEMENT;
REVIEW;
SAFETY;
SICKLE CELL ANEMIA;
SOCIOECONOMICS;
THALASSEMIA;
TUBERCULOSIS;
WORLD HEALTH ORGANIZATION;
|
|
EID: 33645875903
PISSN: 13649027
EISSN: 13649027
Source Type: Journal
DOI: 10.2165/00124363-200519050-00005 Document Type: Review |
|
Times cited : (5)
|
|
References (5)
|
